Quick Answer
NUTRA PHARMA CORP reported Total Assets of $599.5 thousand for fiscal year 2024.
NUTRA PHARMA CORP Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $599.5K | -6.4% |
| 2023 | $640.4K | -15.2% |
| 2022 | $754.9K | -3.2% |
| 2021 | $780.0K | +158.5% |
| 2020 | $301.8K | -11.2% |
| 2019 | $339.8K | +140.3% |
| 2018 | $141.4K | -63.7% |
| 2017 | $389.6K | +81.8% |
| 2016 | $214.3K | -44.7% |
| 2015 | $387.6K | +0.1% |
| 2014 | $387.3K | +199.4% |
| 2013 | $129.4K | -57.3% |
| 2012 | $302.9K | +32.1% |
| 2011 | $229.3K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $859.1K | +36.2% | +43.3% |
| December 31, 2024 | $599.5K | -6.4% | +7.3% |
| September 30, 2024 | $558.8K | -21.4% | -11.4% |
| June 30, 2024 | $631.0K | -15.7% | +1.6% |
| March 31, 2024 | $620.7K | -14.4% | -3.1% |
| December 31, 2023 | $640.4K | -15.2% | -10.0% |
| September 30, 2023 | $711.3K | +3.0% | -4.9% |
| June 30, 2023 | $748.2K | -1.1% | +3.2% |
- NUTRA PHARMA CORP showed a decrease of -6.4% in Total Assets compared to the prior fiscal year.
- Over the 2011–2024 period, NUTRA PHARMA CORP’s total assets has grown by 161.4% (from $229.3 thousand to $599.5 thousand).
- The most recent figure is from NUTRA PHARMA CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: